$FRX Stock | Forest Laboratories, Inc. (FRX) Company Research

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$FRX Forest Laboratories, Inc. FRX Company Overview 

Stock Message Board http://investorshangout.com/search?q=FRX&...mp;yt1=Go!

Last Updated: Sunday, November 10, 2013 2:52:10 PM

Forest Laboratories, Inc. FRX Current Price and Quotes
Last Price 48.00
Previous Close 47.31 Open 47.23
Daily Range 48.01 - 47.18 52wk Range 48.00 - 31.71
Volume 1,284,713 Dividend N/A
Average Vol (3m) 1,420,601 Yield N/A
Forest Laboratories, Inc. FRX
Company Information

909 Third Avenue
New York, NY 10022-4731

Website: http://www.frx.com
Phone: (212) 421-7850

Forest Laboratories, Inc. FRX
Not Available

Forest Laboratories, Inc. FRX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000038074
Fiscal Year End 3/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Forest Laboratories, Inc. FRX
FRX Security Details

Share Structure

Market Value1 $11,894,496,420 a/o Nov 08, 2013
Shares Outstanding 268,438,195 a/o Aug 06, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.1
Shareholders

Shareholders of Record 1,316 a/o May 30, 2008
Security Notes

New Issue=10-58 150,000 shs at $2 1/2 by Greenfield & Co., Inc.
Reclassified=7-81 Class A Com as Com Basis: sh for sh
Latest Addt'l & Secondary Issue=2-92 3,000,000 shs at $36.625 by Lehman Brothers et al.
Cap. Change=shs increased by 2 for 1 split. Ex-date=03-26-98. Rec. date=03-05-98. Pay. date=03-25-98.
Capital Change=shs increased by 2 for 1 split. Ex-date=01/12/2001. Rec date=12/26/2000. Pay date=01/11/2001.
Capital Change=shs increased by 2 for 1 split. Ex-date=01/09/2003. Rec date=12/23/2002. Pay date=01/08/2003.
Short Selling Data

Short Interest  (%)
Significant Failures to Deliver  No
Transfer Agent(s)

BNYMellon Shareowner Services

Forest Laboratories, Inc. FRX Financials
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue 3,096,975 4,565,680 4,390,132 4,157,390
Cost of Revenue 649,083 998,087 963,981 924,346
Gross Profit 2,447,892 3,567,593 3,426,151 3,233,044
Operating Expenses

Research and Development 963,594 796,932 715,872 1,053,561
Sales, General and Admin. 1,558,306 1,553,337 1,402,111 1,264,269
Non-Recurring Items - - - -
Other - - - -
Operating Income (74,008) 1,217,324 1,308,168 915,214
Income From Continuing Operations

Add'l Income/Expense Items 29,150 20,364 29,568 35,472
Earnings Before Interest and Tax (44,858) 1,237,688 1,337,736 950,686
Interest Expense - - - -
Earnings Before Tax (44,858) 1,237,688 1,337,736 950,686
Income Tax (12,755) 258,630 290,966 268,303
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (32,103) 979,058 1,046,770 682,383
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (32,103) 979,058 1,046,770 682,383
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (32,103) 979,058 1,046,770 682,383

Forest Laboratories, Inc. FRX Recent News

Nov 7, 2013 The Zacks Analyst Blog Highlights: Macy's, Shire, Forest Laboratories, Salix Pharmaceuticals and NPS Pharmaceuticals
Nov 7, 2013 Forest Laboratories, Inc. Announces Settlement of BYSTOLIC(R) Patent Litigation
Nov 1, 2013 Marketing Approval, Quarterly Reports, and Donation - Research Report on Allergan, Forest, Cubist, Sanofi, and The Medicines Company
Oct 31, 2013 Pre-Market Review: Celgene Corp., Forest Laboratories Inc., Peregrine Pharma Inc., and Edwards Lifesciences Corp.
Oct 25, 2013 Forest Laboratories names Alex Kelly Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations
Oct 24, 2013 Mallinckrodt Pharmaceuticals Announces Executive Appointments
Oct 22, 2013 Forest Laboratories, Inc. Reports Fiscal Year Second Quarter 2014 Diluted Earnings Per Share of $0.26 Including Effect of $0.10 Per Share of Acquisition Amortization
Oct 2, 2013 Forest Laboratories, Inc. Files Additional Lawsuit against First Time US Generics LLC for Infringement of SAVELLA(R) Patents
Oct 1, 2013 Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Second Quarter Earnings
Sep 30, 2013 Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin

1
2
3
next >

FRX Forest Laboratories, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=FRX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/FRX/quote
Stock Chart http://www.otcmarkets.com/stock/FRX/chart
Company Info http://www.otcmarkets.com/stock/FRX/company-info
Recent News http://www.otcmarkets.com/stock/FRX/news
Financials http://www.otcmarkets.com/stock/FRX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/FRX/filings
Short Sales http://www.otcmarkets.com/stock/FRX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/FRX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/FRX/research
Summary http://finance.yahoo.com/q?s=FRX
Historical Prices http://finance.yahoo.com/q/hp?s=FRX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=FRX
Basic Chart http://finance.yahoo.com/q/bc?s=FRX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=FRX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=FRX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=FRX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=FRX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=FRX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=FRX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=FRX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=FRX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=FRX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=FRX
Balance Sheet http://finance.yahoo.com/q/bs?s=FRX
Cash Flow http://finance.yahoo.com/q/cf?s=FRX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/FRX
Market Watch http://www.marketwatch.com/investing/stock/FRX
Bloomberg http://www.bloomberg.com/quote/FRX:US
Morningstar http://quotes.morningstar.com/stock/s?t=FRX
Bussinessweek http://investing.businessweek.com/research/st...ticker=FRX
Barchart http://www.barchart.com/quotes/stocks/FRX
OTC Short Report http://otcshortreport.com/index.php?index=FRX
Investopedia http://www.investopedia.com/markets/stocks/FRX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSL Names Deborah Waterhouse as CEO in Strategic Move

Updated Category News Views 8

A Key Transition: Deborah Waterhouse Takes the Helm In a move that's sure to jolt the biopharma sphere, CSL Limited just handed the CEO reins over to Deborah Waterhouse. Set to start officially on February 1, 2027, this strategic appointment seems well plotted after a diligent global hunt by CSL's board for someone who can drive their enterprise into its next surge of...

Continue Reading
Bolt Teams with NVIDIA for Europe AV Expansion

Updated Category News Views 2

Racing Towards an Autonomous Future Well, hold onto your seats because the European roads will soon witness one hell of a technological trip—with an autonomous twist. Bolt, in cahoots with NVIDIA and Lucid, is plotting to roll out a massive fleet of autonomous vehicles just gearing up to hit the streets. The project's kicking off in Madrid in 2027 and aims to sprinkle...

Continue Reading
Ashford Hospitality Trust: Fee Waiver and Share Buyback

Updated Category News Views 3

Strategic Moves in a Challenging Market When it rains, it pours. Ashford Hospitality Trust (NYSE: AHT), the real estate investment trust that's got its fingers in the hotel industry pie, is shaking things up with some bold maneuvers. The company just dropped a bombshell: it's waiving a $17 million advisory fee, buying back shares, and terminating its at-the-market (ATM)...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 9

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Partner Climbs 25 Spots on ENR's Environmental Firm List

Updated Category News Views 11

A Leap Forward in Environmental Expertise Alright, folks, let's dive into some real grit. Partner Engineering and Science, Inc. has pulled off a neat little trick. They've jumped up 25 spots on the 2026 Engineering News-Record's Top 200 Environmental Firms list. They’ve been making this list for 14 years straight, and that's no fluke. It's a hard road, especially when...

Continue Reading
Network Brainiacs Expands Footprint into Maryland Market

Updated Category News Views 10

Network Brainiacs Steps into Maryland Territory If you're in the tech services game, expansion stories are the bread and butter of this business. Network Brainiacs, a seasoned veteran in the managed IT and cybersecurity sectors, has taken their first big step into Maryland by acquiring Computer Enhancement Systems (CES), a notable player in the field, as of September 1,...

Continue Reading
Glint: Lovense's New Era in Intimacy Tech

Updated Category News Views 6

From Thrill to Touch: The Glint Debut Screw the traditional remote control for sex toys! Lovense is straight up flipping the script with Glint. This isn't about adding more buttons or connecting another app. We're talking about a butt plug that lets your partner's thrust set the whole vibe. Forget fumbling with phones in the heat of the moment—this toy syncs your...

Continue Reading
Millrose Investors Face Unveiling of Financial Missteps

Updated Category News Views 11

A Cold Shower for Millrose Properties' Investors Investing in Millrose Properties, Inc. (NYSE: MRP) didn't quite pan out as some folks hoped. On the heels of Hunterbrook's report about dubious deals, the Company's stock tumbled 8.53%, smacking investors with a not-so-gentle reminder of market realities. Sure, stocks can dip and dive like a rollercoaster, but when it...

Continue Reading
Oberndorf, Bascom Snap Up San Jose Flats for $53M

Updated Category News Views 11

Well, isn’t this just a spicy tidbit from the real estate frontier? Oberndorf Real Estate Management and The Bascom Group are strutting into San Jose with a hefty $53.1 million deal that snags them the Museum Park Apartments. These guys aren't just dipping their toes; they’re cannonballing into the market with style. Now, exactly what does it mean for you and me?...

Continue Reading
Papa John's Legal Woes: Class Action Lawsuit Hits Hard

Updated Category News Views 6

A Hot Slice of Legal Trouble for Papa John's Ah, what a steaming mess Papa John's seems to have landed in! And not the good kind with extra cheese. The lawsuit bell tolls for them, reminding investors that even the big guys can get burned. This time, it's for allegedly not having their story straight when it came to market expectations and promotional tactics. Under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Rancho Mission Viejo: Leading the Way in Wellness Real Estate

Updated Category News Views 202

Rancho Mission Viejo Recognized Globally for Wellness Development The Ranch stands out as a model for wellness communities and showcases the impact on individual lives. This 23,000-acre master-planned community and functional cattle ranch has achieved global recognition as one of the largest intentional wellness real estate developments. A Testament to Community Design As...

Continue Reading
Revolutionizing Patient Access with AI: The New Trial Finder

Updated Category News Views 177

Introducing the Future of Clinical Trials The world of radiopharmaceuticals is changing rapidly, with an innovative new tool set to revolutionize the way patients and healthcare providers access critical information about clinical trials. The Radiopharmaceutical Trial Finder, backed by the ICPO Foundation, was developed through a collaboration between WARMTH and...

Continue Reading
Semler Scientific Faces Legal Challenges Amid Controversy

Updated Category News Views 157

Semler Scientific Under Legal Scrutiny Semler Scientific, Inc. is currently facing a class action lawsuit that sheds light on serious allegations regarding their securities practices. Shareholders of the company, identified by the ticker SMLR, are encouraged to be proactive amidst these developments. The lawsuit primarily alleges violations of federal securities exchanges...

Continue Reading
Charles Dayoub Joins The Willis Law Group Fraud Team

Updated Category News Views 207

Charles Dayoub Enhances The Willis Law Group’s Fraud Team We are delighted to announce that Charles Dayoub has joined The Willis Law Group P.L.L.C., bringing with him a wealth of experience with over 18 years in law and extensive expertise in executive positions. His previous role at a prominent law firm involved dealing with government receivables and regulatory...

Continue Reading
Evaluating Revolution Medicines' Future Potential and Progress

Updated Category News Views 168

Revolution Medicines Maintains Positive Outlook Piper Sandler has sustained an optimistic outlook regarding Revolution Medicines (NASDAQ: RVMD), reaffirming its Overweight rating with a specified price target of $57.00. This commitment to the stock's rating comes after recent developments linked to the company’s Phase I trial, which is focused on RMC-6236, a potential...

Continue Reading